HomeIMMNOV • STO
add
Immunovia AB (publ)
Previous close
kr 0.20
Day range
kr 0.20 - kr 0.20
Year range
kr 0.15 - kr 0.75
Market cap
136.22M SEK
Avg Volume
6.27M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 354.00K | -22.20% |
Operating expense | 16.63M | -45.69% |
Net income | -17.33M | -664.46% |
Net profit margin | -4.90K | -825.51% |
Earnings per share | -0.03 | — |
EBITDA | -15.70M | 45.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.46M | 205.94% |
Total assets | 88.21M | 166.97% |
Total liabilities | 23.48M | 9.74% |
Total equity | 64.74M | — |
Shares outstanding | 672.67M | — |
Price to book | 2.02 | — |
Return on assets | -65.06% | — |
Return on capital | -105.39% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -17.33M | -664.46% |
Cash from operations | -19.78M | 30.04% |
Cash from investing | 11.39M | — |
Cash from financing | 70.79M | 6,880.75% |
Net change in cash | 62.28M | 315.59% |
Free cash flow | -10.02M | 60.21% |
About
Founded
2007
Website
Employees
13
